Data released early to show lung drug Spiriva safe | Reuters
Links shared publicly online about this topic.
- 2,601total visits
Data released early to show lung drug Spiriva safe | Reuters
LONDON (Reuters) - Results of a clinical study to be presented next month show the blockbuster inhaled lung drug Spiriva, marketed by Pfizer and Boehringer Ingelheim, actually cuts heart risk, researchers
View full resource at reuters.com
Tags: Heart, Lung, COPD Medication, Drug, Spiriva, Pfizer, Boehringer Ingelheim
Most Recently Shared on September 24, 2008 at 4:05 pm By:
Interesting development on Spiriva risk. 6k-pt study from PFE & BI shows no heart risk. http://tinyurl.com/4dnwcl
Advertisement
